EPA and DHA Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

EPA & DHA Market Analysis

The EPA And DHA Market size is estimated at USD 2.06 billion in 2025, and is expected to reach USD 2.96 billion by 2030, at a CAGR of 7.51% during the forecast period (2025-2030).

The EPA and DHA industry is experiencing significant transformation driven by increasing scientific validation and regulatory support. According to the Global Organization for EPA and DHA Omega-3s (GOED), there are currently more than 42,000 published studies on EPA and DHA, including over 4,000 human clinical trials, demonstrating the robust scientific foundation supporting these ingredients. Major regulatory bodies worldwide, including the FDA and EFSA, have established dietary recommendations and guidelines promoting EPA and DHA consumption, fostering consumer confidence and market growth. This scientific and regulatory backing has led to increased incorporation of EPA and DHA in various product formulations across multiple industries.

The industry is witnessing a notable shift towards sustainable and plant-based sources of EPA and DHA, particularly algae-based alternatives. This transition is driven by environmental concerns and the growing demand for vegan-friendly options. According to the Organization for Economic Cooperation and Development (OECD), the forecast volume of fish oil produced in the European Union is expected to rise to 167.08 thousand tons by 2032, highlighting the need for alternative sources. This has prompted manufacturers to invest in research and development of algae-based EPA and DHA products, leading to innovations in cultivation and extraction technologies.

The market is experiencing rapid product innovation and diversification, particularly in delivery formats and applications. Recent developments include Friesland Campina's March 2024 launch of Biotis DHA FlexP 15 and Biotis DHA FlexP 20, two new algae-based, microencapsulated DHA powders for brain health. Similarly, in February 2024, Epax introduced a full-spectrum oil combining Omegas 3, 9, and 11, specifically targeting skin health supplements. These innovations demonstrate the industry's response to evolving consumer preferences and expanding application possibilities.

The healthcare sector continues to be a significant driver of EPA and DHA demand, supported by growing evidence of their role in preventing chronic conditions. According to the Centers for Disease Control and Prevention, heart disease accounts for 21.4% of all deaths in the United States as of 2022, highlighting the potential market for EPA and DHA in cardiovascular health applications. This has led to increased integration of these ingredients in both prescription medications and over-the-counter supplements, with pharmaceutical companies developing new formulations targeting specific health conditions. The trend is further supported by healthcare professionals increasingly recommending EPA and DHA supplementation as part of preventive healthcare strategies.

EPA & DHA Market Trends

VERSATILE HEALTH BENEFITS OF DHA IN FOOD AND FEED APPLICATIONS

The increasing consumer preference for tailored health solutions has led to a surge in demand for DHA-infused food and feed products. As individuals seek nutritionally enriched options, there is a noticeable transition toward products that offer versatile health benefits derived from DHA sources. The American Heart Association's recommendation of 1,000 milligrams of DHA per day for patients with coronary heart disease and two meals of oily fish per week for people without heart disease has significantly shaped consumer preferences. According to the Centers for Disease Control (CDC), just over 42% of Americans were obese in 2021, and obesity-related diseases such as cardiovascular diseases, hypertension, and type 2 diabetes are rising. Moreover, the Global Organization for DHA Omega-3s (GOED) established a daily recommendation for DHA and EPA intake of 700-1,000 mg for lactating or pregnant women, 500 mg for healthy adults, and more than 1g depending on additional health conditions.

The multifaceted health benefits and practical applications of DHA in animal feed formulations exert a substantial influence on their rising preference. For instance, incorporating DHA in aquafeed formulations has enhanced the overall health and quality of farmed fish and seafood products. Moreover, EPA & DHA have been utilized to enrich poultry chicken feed to improve poultry health, growth, immune function, and the quality of poultry products. In response to this evolving market demand, companies like Devenish and Mara Renewables Corporation launched the strategic initiative Humanativ in June 2021. This collaboration aims to enrich animal feed with an omega-3 DHA solution, targeting significant health benefits for consumers of meat and eggs through the algae-based OmegaPro product.

IMMENSE GROWTH IN CONCENTRATED FORMS OF OMEGA-3 INGREDIENTS

Omega-3 concentrates are highly purified oils that supply merely the desired fatty acids, EPA sources, and DHA in a convenient, small dosage. This enables convenient intake of significant quantities and the condition for specific use. High-concentrate fish oils, high-purity krill oils, and purified algal oils are expected to increase in popularity as supplements. Research on new product formulation is being carried out to tailor new products, focusing on improved absorption/utilization of omega-3 concentrates in dietary supplements and pharmaceuticals, with further consumer benefits. Through numerous initiatives, suppliers are investing in the production of highly concentrated omega-3 products and are counting on increased demand to drive sales.

The market for concentrates has been experiencing significant growth, with major companies making strategic investments to capitalize on existing opportunities. For instance, in March 2024, Epax, a wholly owned subsidiary of Norwegian company Pelagia AS, invested USD 40 million in its facility in Alesund to implement next-level distillation technology for ultra-concentrated omega-3 production. Similarly, in April 2023, MiAlgae, a Scottish biotech company, introduced NaturAlgae, an omega-3 dry powder derived from microalgae cultivated using co-products from the Scotch whisky industry. This innovative product offers a high concentration of docosahexaenoic acid (DHA) and other beneficial oils, making it a potent source of omega-3. Additionally, in March 2024, Friesland Campina Ingredients launched Biotis DHA FlexP 15 and Biotis DHA FlexP 20, two new algae-based, microencapsulated DHA powders for brain health.

Segment Analysis: By Type

DHA Segment in EPA and DHA Market

The Docosahexaenoic Acid (DHA) segment dominates the EPA and DHA market, commanding approximately 79% market share in 2024, driven primarily by its extensive incorporation in infant formulae and nutritional products targeting children's health. DHA's prominence stems from its role as an essential building block for brain growth and retinal maturation in infants, making it a crucial ingredient in infant nutrition. The segment's growth is further propelled by its widespread application in prenatal and infant nutrition, particularly as health professionals and regulatory bodies increasingly recommend DHA supplementation during pregnancy and early childhood development. The segment is experiencing robust growth with a projected CAGR of around 8% from 2024 to 2029, supported by expanding applications in functional foods, dietary supplements, and pharmaceutical formulations. The rising consumer awareness about DHA's benefits in cognitive development, cardiovascular health, and visual function has led to increased product launches and innovations in DHA supplements market across various sectors.

EPA Segment in EPA and DHA Market

The Eicosapentaenoic Acid (EPA) segment represents a significant portion of the market, with its growth driven by increasing clinical evidence supporting its efficacy in cardiovascular health and inflammatory conditions. The segment is witnessing substantial development in pharmaceutical applications, particularly in formulations targeting heart health and blood lipid management. EPA's anti-inflammatory properties have sparked interest in its therapeutic potential for various health conditions, leading to increased research and development activities. The segment's expansion is further supported by growing consumer awareness about preventive healthcare and the rising demand for natural alternatives in managing chronic conditions. Manufacturers are actively developing standalone EPA concentrates for nutraceutical and pharmaceutical formulations, predominantly for cardiovascular prevention. The segment also benefits from its applications in animal feed, where EPA supplementation has shown promising results in improving animal health and product quality.

Segment Analysis: By Source

Fish Oil Segment in EPA and DHA Market

Fish oil dominates the EPA and DHA market, commanding approximately 42% market share in 2024. The segment's prominence is primarily driven by the increasing awareness of health benefits associated with fish oil-derived EPA and DHA, particularly in cardiovascular health and cognitive function. Fish oil remains the most cost-effective and widely available source of EPA and DHA, with established supply chains and processing infrastructure. The segment's growth is further supported by its extensive application across various industries, including dietary supplements, infant formula, and pharmaceutical products. Fish oil-derived EPA and DHA are particularly valued for their high bioavailability and natural concentration of these essential fatty acids, making them the preferred choice for manufacturers and consumers alike.

Algae Oil Segment in EPA and DHA Market

The algae oil segment is experiencing the most rapid growth in the EPA and DHA market, with a projected growth rate of approximately 8% from 2024 to 2029. This remarkable growth is driven by increasing consumer preference for plant-based alternatives and sustainable sourcing practices. Algae-based EPA and DHA products are gaining significant traction among vegetarian and vegan consumers, as well as environmentally conscious individuals seeking alternatives to traditional marine sources. The segment's expansion is further supported by technological advancements in algae cultivation and oil extraction processes, which have improved both the quality and efficiency of production. Manufacturers are increasingly investing in algae-based solutions to meet the growing demand for sustainable and plant-based omega-3 fatty acids.

Remaining Segments in EPA and DHA Market by Source

The krill oil and other sources segments play significant roles in diversifying the EPA and DHA market offerings. Krill oil is valued for its unique phospholipid-bound form of omega-3s and natural antioxidant content, making it an attractive alternative for consumers seeking enhanced bioavailability. The other sources segment, which includes various marine and plant-based sources, contributes to market innovation by providing alternative extraction methods and novel applications. These segments cater to specific consumer preferences and applications, offering manufacturers flexibility in product development and formulation while ensuring a stable supply chain through source diversification.

Segment Analysis: By Application

Dietary Supplements Segment in EPA and DHA Market

The dietary supplements segment dominates the EPA and DHA market, holding approximately 43% market share in 2024. This significant market position is primarily driven by the growing health consciousness among consumers worldwide and their increasing focus on preventive healthcare measures. EPA and DHA full form supplements are commonly available in the form of fish oil capsules or soft gels, containing concentrated amounts of these essential fatty acids derived from fish oil. The segment's growth is further bolstered by the rising demand for vegan-friendly EPA and DHA supplements, particularly algae-derived options that cater to vegetarian and vegan lifestyles. The convenience of EPA and DHA supplements in different formats like soft gels, capsules, and liquid formulations allows individuals to easily include these essential nutrients in their everyday regimen. Additionally, personalized nutrition trends are gaining traction, with companies offering customized supplementation options based on individual needs, health profiles, and genetic variations.

Fortified Food and Beverages Segment in EPA and DHA Market

The fortified food and beverages segment is projected to experience the highest growth rate of approximately 9% during the forecast period 2024-2029. This remarkable growth is attributed to increasing consumer awareness about balanced diets and the role of specific nutrients in maintaining good health. Manufacturers are actively fortifying a wide range of food and beverage products with eicosapentaenoic acid and docosahexaenoic acid, including dairy alternatives, juices, snacks, and bakery items. The integration of EPA and DHA into functional foods and beverages is gaining momentum, driven by growing consumer interest in products offering additional health benefits beyond basic nutrition. The Global Organization for EPA and DHA Omega-3s (GOED) has established daily recommendations for EPA and DHA intake, which has further encouraged manufacturers to develop innovative fortified products. The trend is particularly strong in the beverage sector, where omega-3 enriched drinks are becoming increasingly popular among health-conscious consumers.

Remaining Segments in EPA and DHA Market by Application

The remaining segments in the EPA and DHA market include infant formula, pharmaceuticals, and other applications, each serving distinct market needs. The infant formula segment plays a crucial role in early childhood development, with manufacturers incorporating EPA and DHA to support brain development and cognitive function in infants. The pharmaceutical segment utilizes these omega-3 fatty acids in various therapeutic applications, particularly for cardiovascular health and inflammatory conditions. The other applications segment encompasses animal feed, aquafeed, and clinical nutrition, where EPA and DHA are used for improving animal health and nutrition. These segments collectively contribute to the market's diversity and demonstrate the versatile applications of EPA and DHA across different industries, from infant nutrition to therapeutic treatments and animal feed formulations.

EPA And DHA Market Geography Segment Analysis

EPA and DHA Market in North America

The North American EPA and DHA market encompasses the United States, Canada, and Mexico, with each country showing distinct market characteristics and growth patterns. The region benefits from high consumer awareness regarding the health benefits of omega-3 fatty acids, particularly in cardiovascular health and cognitive function. The market is driven by increasing health consciousness, the rising prevalence of lifestyle diseases, and growing demand for dietary supplements. The presence of major manufacturers and robust distribution networks further strengthens the regional market dynamics.

EPA and DHA Market in United States

The United States dominates the North American EPA and DHA market, holding approximately 84% market share in the region. The market is primarily driven by rising health consciousness and increased diseases caused by EPA and DHA deficiency. The country's robust pharmaceutical and nutraceutical sectors contribute significantly to market growth. The presence of stringent regulatory frameworks and increasing consumer awareness about preventive healthcare measures further boost market development. The US market also benefits from innovative product launches and strategic initiatives by key market players to expand their product portfolios.

EPA and DHA Market in Mexico

Mexico emerges as the fastest-growing market in North America, with a projected growth rate of approximately 8% during 2024-2029. The country's market growth is fueled by increasing consumer awareness about the health benefits of omega-3 supplements and rising disposable income. The Mexican market shows particular strength in the dietary supplements sector, with growing demand for EPA and DHA-based products. The country's expanding pharmaceutical industry and increasing focus on preventive healthcare contribute to market growth. Additionally, manufacturers are actively introducing new products and forming strategic partnerships to capitalize on the growing market opportunities.

EPA and DHA Market in Europe

The European EPA and DHA market demonstrates a sophisticated landscape with significant contributions from countries including the United Kingdom, Germany, France, Spain, Italy, and Russia. The region's market is characterized by strong research and development activities, innovative product launches, and increasing consumer awareness about health supplements. The presence of major manufacturers and robust regulatory frameworks further strengthens the market structure. The region shows particular strength in sustainable and plant-based omega-3 sources, reflecting growing environmental consciousness among consumers.

EPA and DHA Market in United Kingdom

The United Kingdom leads the European market, commanding approximately 18% of the regional market share. The country's market is characterized by strong demand for EPA and DHA supplements, particularly driven by increasing health consciousness and rising cardiovascular health concerns. The UK market shows significant innovation in product development, especially in sustainable and plant-based alternatives. The presence of established manufacturers and robust distribution networks further strengthens the market position.

EPA and DHA Market in France

France demonstrates the highest growth potential in the European region, with a projected growth rate of approximately 7% during 2024-2029. The French market shows particular strength in functional foods and beverages incorporating EPA and DHA. The country's focus on research and development, coupled with increasing consumer preference for natural health supplements, drives market growth. The market also benefits from strong distribution networks and increasing awareness about the health benefits of omega-3 fatty acids.

EPA and DHA Market in Asia-Pacific

The Asia-Pacific region represents a dynamic market for EPA and DHA, encompassing major economies like China, Japan, India, and Australia. The region demonstrates strong growth potential driven by increasing health awareness, rising disposable income, and growing demand for functional foods and dietary supplements. The market benefits from the presence of both established manufacturers and emerging players, creating a competitive landscape that fosters innovation and market expansion.

EPA and DHA Market in China

China emerges as the dominant force in the Asia-Pacific EPA and DHA market. The country's market benefits from its large population base and increasing health consciousness among consumers. The growing prevalence of lifestyle diseases and rising demand for nutritional supplements drive market growth. China's strong presence in the infant nutrition sector and increasing focus on preventive healthcare measures further strengthen its market position.

EPA and DHA Market in India

India represents the fastest-growing market in the Asia-Pacific region. The country's market growth is driven by increasing awareness about nutritional supplements, rising disposable income, and growing health consciousness among consumers. The market shows particular strength in the pharmaceutical and nutraceutical sectors. India's expanding retail network and increasing penetration of health supplements in tier-2 and tier-3 cities contribute to market growth.

EPA and DHA Market in South America

The South American EPA and DHA market, primarily represented by Brazil and Argentina, shows promising growth potential driven by increasing health awareness and rising demand for nutritional supplements. Brazil emerges as both the largest and fastest-growing market in the region, benefiting from its large population base and growing health consciousness. The market shows particular strength in the dietary supplements sector, with increasing demand for omega-3 products. The region's market growth is supported by expanding distribution networks and increasing consumer awareness about the health benefits of EPA and DHA supplements.

EPA and DHA Market in Middle East and Africa

The Middle East and African EPA and DHA market, with key countries including the United Arab Emirates and Saudi Arabia, demonstrates growing potential driven by increasing health awareness and rising disposable income. The United Arab Emirates emerges as both the largest and fastest-growing market in the region, supported by its strong healthcare infrastructure and increasing consumer awareness about nutritional supplements. The region's market benefits from growing urbanization, expanding retail networks, and increasing penetration of health supplements. The market shows particular strength in the dietary supplements sector, with growing demand for premium health products.